Rutgeerts P - Search Results

1

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.

Schnitzler F, Fidder H, Ferrante M, Ballet V, Noman M, Van Assche G, Spitz B, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2011 Sep;17(9):1846-54. doi: 10.1002/ibd.21583. Epub 2011 Jan 6. Inflamm Bowel Dis. 2011. PMID: 21830263

2

Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.

Jürgens M, Mahachie John JM, Cleynen I, Schnitzler F, Fidder H, van Moerkercke W, Ballet V, Noman M, Hoffman I, van Assche G, Rutgeerts PJ, van Steen K, Vermeire S. Jürgens M, et al. Clin Gastroenterol Hepatol. 2011 May;9(5):421-7.e1. doi: 10.1016/j.cgh.2011.02.008. Epub 2011 Feb 17. Clin Gastroenterol Hepatol. 2011. PMID: 21334460

3

Drug safety evaluation of certolizumab pegol.

Ferrante M, Vermeire S, Rutgeerts PJ. Ferrante M, et al. Expert Opin Drug Saf. 2014 Feb;13(2):255-66. doi: 10.1517/14740338.2014.851666. Epub 2013 Oct 25. Expert Opin Drug Saf. 2014. PMID: 24156537 Review.

4

Antiadhesion molecule therapy in inflammatory bowel disease.

van Assche G, Rutgeerts P. van Assche G, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2002 Jul;8(4):291-300. doi: 10.1097/00054725-200207000-00009. Inflamm Bowel Dis. 2002. PMID: 12131614 Review.

5

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.

Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P. Baert F, et al. Among authors: rutgeerts p. N Engl J Med. 2003 Feb 13;348(7):601-8. doi: 10.1056/NEJMoa020888. N Engl J Med. 2003. PMID: 12584368 Free article. Clinical Trial.

6

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.

Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, Joossens S, Bossuyt X, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Gastroenterology. 2003 Jul;125(1):32-9. doi: 10.1016/s0016-5085(03)00701-7. Gastroenterology. 2003. PMID: 12851868 Clinical Trial.

7

Medical therapy for Crohn's disease strictures.

Van Assche G, Geboes K, Rutgeerts P. Van Assche G, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Jan;10(1):55-60. doi: 10.1097/00054725-200401000-00009. Inflamm Bowel Dis. 2004. PMID: 15058528 Review.

8

Optimizing anti-TNF treatment in inflammatory bowel disease.

Rutgeerts P, Van Assche G, Vermeire S. Rutgeerts P, et al. Gastroenterology. 2004 May;126(6):1593-610. doi: 10.1053/j.gastro.2004.02.070. Gastroenterology. 2004. PMID: 15168370 Review.

9

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.

Arts J, D'Haens G, Zeegers M, Van Assche G, Hiele M, D'Hoore A, Penninckx F, Vermeire S, Rutgeerts P. Arts J, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Mar;10(2):73-8. doi: 10.1097/00054725-200403000-00002. Inflamm Bowel Dis. 2004. PMID: 15168804

10

Novel biological strategies in inflammatory bowel diseases.

Vermeire S, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Feb;10 Suppl 1:S44-51. doi: 10.1097/00054725-200402001-00010. Inflamm Bowel Dis. 2004. PMID: 15168831 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

727 results

Search Page

Filters